Gene Therapy Clinical Trials Market Strengthens Global Biotech Investments
Gene Therapy Clinical Trials Market ( By Therapy Modality: In vivo Gene Therapy, Ex vivo Gene-modified Cell Therapy; By Vector/Delivery Platform: AAV, Lentiviral Vectors, Adenoviral/Oncolytic & Others, Non-viral, Genome Editing; By Therapeutic Area: Oncology, Rare/Genetic & Metabolic Disorders, Ophthalmology, Hematology, Neurology/CNS, Cardiovascular Diseases, Infectious Diseases, Others; By Clinical Phase: Phase I/ I/II, Phase II, Phase III & Pivotal/Confirmatory, Post-marketing/Long-term Follow-up (LTFU) cohorts; By Route of Administration: Intravenous/Systemic, Intravitreal/Subretinal, Intrathecal/Intracerebroventricular, Intratumoral/Regional, Hepatic-targeted, Intramuscular & Others; By Region: North America, Asia Pacific, Europe, Latin America, Middle East and Africa) Global Analysis, Size, Trends, Leading Companies, Regional Outlook and Forecast 2026 to 2035.
Last Updated : 16 March 2026
Category: Biotechnology
Insight Code: 6068
Format: PDF / PPT / Excel